Overview

Ibuprofen 5% Topical Gel CIPT

Status:
Completed

Trial end date:
2013-02-01

Target enrollment:

Participant gender:

Summary

This study will determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause irritation after repeated topical application to the healthy skin of human subjects under controlled conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Ibuprofen